Siga Technologies (SIGA) Net Cash Flow (2010 - 2025)
Siga Technologies (SIGA) posted Net Cash Flow of -$10.5 million for Q3 2025, down 152.04% on a QoQ basis from $20.2 million in Q2 2025, and down 36.82% year-over-year from -$16.6 million in Q3 2024.
Siga Technologies (SIGA) Net Cash Flow (2010 - 2025) Analysis & Trends
Siga Technologies' Net Cash Flow history runs 16 years deep, the most recent figure standing at -$10.5 million for Q3 2025.
- Quarterly Net Cash Flow fell 36.82% year-over-year to -$10.5 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $16.6 million (up 215.07% YoY) and the FY2024 annual result came in at $5.3 million, down 89.77% from the prior year.
- Net Cash Flow was -$10.5 million for Q3 2025 at Siga Technologies, down from $20.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $79.0 million in Q4 2023 and bottomed at -$39.5 million in Q2 2023.
- A 5-year average of $2.8 million and a median of -$5.7 million in 2021 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 381.62% — and 2023, when it surged 821.16%.
- Siga Technologies' Net Cash Flow stood at $10.3 million in 2021, then sank by 206.2% to -$11.0 million in 2022, then jumped by 821.16% to $79.0 million in 2023, then retreated by 28.98% to $56.1 million in 2024, then tumbled by 118.72% to -$10.5 million in 2025.
- Business Quant data shows SIGA's Net Cash Flow at -$10.5 million in Q3 2025, $20.2 million in Q2 2025, and $6.9 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.51 Mn |
| Sep 30, 2025 | -10.51 Mn |
| Jun 30, 2025 | 20.19 Mn |
| Jun 30, 2025 | 20.19 Mn |
| Mar 31, 2025 | 6.87 Mn |
| Mar 31, 2025 | 6.87 Mn |
| Dec 31, 2024 | 56.13 Mn |
| Dec 31, 2024 | 56.13 Mn |
| Sep 30, 2024 | -7.68 Mn |
| Sep 30, 2024 | -7.68 Mn |
| Jun 30, 2024 | -36.92 Mn |
| Jun 30, 2024 | -36.92 Mn |
| Mar 31, 2024 | -6.28 Mn |
| Mar 31, 2024 | -6.28 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -39.47 Mn |
| Jun 30, 2023 | -39.47 Mn |